These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 16462627)

  • 1. [What are the representations of remission for the psychiatrist?].
    Pascal JC
    Encephale; 2005 Dec; 31 Pt 2():S11-2. PubMed ID: 16462627
    [No Abstract]   [Full Text] [Related]  

  • 2. [What are the representations of remission for the patient?].
    Lançon C
    Encephale; 2005 Dec; 31 Pt 2():S13-4. PubMed ID: 16462628
    [No Abstract]   [Full Text] [Related]  

  • 3. Addressing clozapine under-prescribing and barriers to initiation: a psychiatrist, advanced practice provider, and trainee survey.
    Leung JG; Cusimano J; Gannon JM; Milgrom O; Valcourt SC; Stoklosa JB; Kemp M; Olsufka W; Vickery PB; Nichols SD; Crouse EL; Paxos C; Johnson EK; Palmer BA
    Int Clin Psychopharmacol; 2019 Sep; 34(5):247-256. PubMed ID: 31107831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psychiatrists' Attitude and Use of Second-generation Antipsychotics for the Treatment of Schizophrenia in Taiwan.
    Chen CK; Su HH; Sun IW
    East Asian Arch Psychiatry; 2017 Sep; 27(3):91-6. PubMed ID: 28993541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psychiatrists' attitude towards the use of clozapine in the treatment of refractory schizophrenia: A nationwide survey.
    Daod E; Krivoy A; Shoval G; Zubedat S; Lally J; Vadas L; Weizman A; Reshef A; Bloch B
    Psychiatry Res; 2019 May; 275():155-161. PubMed ID: 30913436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psychiatrists' perceptions of medication adherence among patients with schizophrenia: An international survey.
    Kurokawa S; Kishimoto T; Su KP; Chang JP; Chang HC; Yu X; Rodrigues-Silva N; Nielsen J; Unadkat A; Castle D; Haddad PM; Rocha D; Gadelha A; Kaliora S; Petrides G; Agid O; Tazawa Y; Takamiya A; Horigome T; Kane JM
    Schizophr Res; 2019 Sep; 211():105-107. PubMed ID: 31371039
    [No Abstract]   [Full Text] [Related]  

  • 7. Psychopharmacotherapy and remission of patients with schizophrenia.
    Degmecić D; Pozgain I; Filaković P; Dodig-Curković K; Mihanović M
    Coll Antropol; 2009 Jun; 33(2):547-51. PubMed ID: 19662777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Are we still talking to our patients with schizophrenia?
    Keith SJ
    Am J Psychiatry; 2006 Mar; 163(3):362-4. PubMed ID: 16513853
    [No Abstract]   [Full Text] [Related]  

  • 9. [Criteria of remission in schizophrenia].
    Gorwood P
    Encephale; 2005 Dec; 31 Pt 2():S18-20. PubMed ID: 16462630
    [No Abstract]   [Full Text] [Related]  

  • 10. Attitudes towards and rationale for antipsychotic polypharmacy among psychiatrists in Nigeria: Characteristics associated with high reported antipsychotic polypharmacy.
    James BO; Omoaregba JO; Raji SO; Imishue OE; Okonoda KM; Nyamali YI; Famuyiwa PA; Correll CU
    Psychiatry Res; 2017 Feb; 248():134-139. PubMed ID: 28063386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improving patient outcomes in schizophrenia: achieving remission.
    Nasrallah HA; Lasser R
    J Psychopharmacol; 2006 Nov; 20(6 Suppl):57-61. PubMed ID: 17046987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Psychiatrists' attitude to antipsychotic depot treatment in patients with first-episode schizophrenia.
    Heres S; Reichhart T; Hamann J; Mendel R; Leucht S; Kissling W
    Eur Psychiatry; 2011; 26(5):297-301. PubMed ID: 20570493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Opinions about long-term treatment of schizophrenia among psychiatrist in Gdansk region].
    Gizińska D; Trzebiatowska IA
    Psychiatr Pol; 2002; 36(6 Suppl):243-8. PubMed ID: 12647445
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survey on schizophrenia treatment in Mexico: perception and antipsychotic prescription patterns.
    Apiquian R; Fresán A; de la Fuente-Sandoval C; Ulloa RE; Nicolini H
    BMC Psychiatry; 2004 Apr; 4():12. PubMed ID: 15109398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Daily life of schizophrenic patients "in remission"].
    Leguay D
    Encephale; 2005 Dec; 31 Pt 2():S24-8. PubMed ID: 16462632
    [No Abstract]   [Full Text] [Related]  

  • 16. Melleril: gone forever!
    Dale MC; Jagus C; Barnes R; Akinpelu I; McWilliam C
    Br J Gen Pract; 2002 Feb; 52(475):155. PubMed ID: 11885828
    [No Abstract]   [Full Text] [Related]  

  • 17. [Cognitive functions and remission].
    Sarfati Y
    Encephale; 2005 Dec; 31 Pt 2():S21-3. PubMed ID: 16462631
    [No Abstract]   [Full Text] [Related]  

  • 18. Relapse prevention in schizophrenia: attitudes of neurologists-psychiatrists.
    Bergiannaki JD; Hatzimanolis J; Liappas J; Sakkas PN; Stefanis CN
    Eur Psychiatry; 2001 Mar; 16(2):90-8. PubMed ID: 11311172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Self-reported prescribing practices for schizophrenic patients among Israeli psychiatrists.
    Heresco-Levy U; Brom D; Greenberg D
    Isr J Psychiatry Relat Sci; 1993; 30(3):164-74. PubMed ID: 7901179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Are all antipsychotics equal?
    Volavka J
    Lancet; 2008 Jul; 372(9634):201-2; author reply 202. PubMed ID: 18640446
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.